CXCR1 Regulates Pulmonary Anti-Pseudomonas Host Defense
- Carevic, M.
- Öz, H.
- Fuchs, K.
- Laval, J.
- Schroth, C.
- Frey, N.
- Hector, A.
- Bilich, T.
- Haug, M.
- Schmidt, A.
- Autenrieth, S.E.
- Bucher, K.
- Beer-Hammer, S.
- Gaggar, A.
- Kneilling, M.
- Benarafa, C.
- Gao, J.L.
- Murphy, P.M.
- Schwarz, S.
- Moepps, B.
- Hartl, D.
- 2016-3-8
Published in:
- Journal of Innate Immunity. - S. Karger AG. - 2016, vol. 8, no. 4, p. 362-373
English
Pseudomonas aeruginosa is a key opportunistic pathogen causing disease in cystic fibrosis (CF) and other lung diseases such as chronic obstructive pulmonary disease (COPD). However, the pulmonary host defense mechanisms regulating anti-P. aeruginosa immunity remain incompletely understood. Here we demonstrate, by studying an airway P. aeruginosa infection model, in vivo bioluminescence imaging, neutrophil effector responses and human airway samples, that the chemokine receptor CXCR1 regulates pulmonary host defense against P. aeruginosa. Mechanistically, CXCR1 regulates anti-Pseudomonas neutrophil responses through modulation of reactive oxygen species and interference with Toll-like receptor 5 expression. These studies define CXCR1 as a novel, noncanonical chemokine receptor that regulates pulmonary anti-Pseudomonas host defense with broad implications for CF, COPD and other infectious lung diseases.
- Language
-
- English
- Open access status
- gold
- Identifiers
-
- DOI 10.1159/000444125
- ISSN 1662-811X
- Persistent URL
- https://sonar.ch/global/documents/34660
Statistics
Document views: 34
File downloads:
- Full-text: 0